Seven or less Fractions is Not the Standard of Care for Intermediate-Risk Prostate Cancer.
View/ Open
Date
2020-03-01ICR Author
Author
Tree, AC
Dearnaley, DP
Type
Journal Article
Metadata
Show full item recordAbstract
Evidence is accumulating for seven and less fractions in localised prostate cancer, including one large randomised trial. However, there is much more evidence yet to come and changing practice in advance of this may be premature. We review the reasons to persist with moderate hypofractionation for prostate cancer radiotherapy, until the results of further phase III studies are known.
Collections
Subject
Humans
Prostatic Neoplasms
Male
Standard of Care
Radiation Dose Hypofractionation
Research team
Clinical Academic Radiotherapy (Dearnaley)
Language
eng
Date accepted
2019-09-20
License start date
2020-03
Citation
Clinical oncology (Royal College of Radiologists (Great Britain)), 2020, 32 (3), pp. 175 - 180
Publisher
ELSEVIER SCIENCE LONDON